Clenbuterol () vs Tezspire (tezepelumab-ekko)
Clenbuterol () vs Tezspire (tezepelumab-ekko)
Clenbuterol is a sympathomimetic amine used primarily for breathing disorders in some countries, but it is not FDA-approved for this use in the United States; it is known for its off-label use as a weight-loss aid and is on the World Anti-Doping Agency's list of banned substances. Tezspire (tezepelumab-ekko) is a prescription medication approved by the FDA for the treatment of severe asthma in individuals 12 years and older, and it works by blocking the action of a protein called thymic stromal lymphopoietin (TSLP) that plays a key role in the inflammation that leads to asthma attacks. When deciding between these medications for respiratory issues, it is crucial to consult a healthcare professional who can evaluate the specific condition, as Clenbuterol is not an approved asthma treatment in the U.S., while Tezspire is specifically designed and approved for severe asthma management.
Difference between Clenbuterol and Tezspire
| Metric | Clenbuterol | Tezspire (tezepelumab-ekko) |
|---|---|---|
| Generic name | Clenbuterol | Tezepelumab |
| Indications | Off-label for weight loss, asthma (outside the US) | Severe asthma |
| Mechanism of action | β2 agonist | Thymic stromal lymphopoietin (TSLP) antagonist |
| Brand names | Dilaterol, Spiropent, Ventipulmin | Tezspire |
| Administrative route | Oral, inhalation | Subcutaneous injection |
| Side effects | Tremors, insomnia, sweating, increased blood pressure, nausea | Injection site reactions, sore throat, headache |
| Contraindications | Cardiac disease, hyperthyroidism, pregnancy | Hypersensitivity to tezepelumab or excipients |
| Drug class | β2 adrenergic agonist | Monoclonal antibody |
| Manufacturer | Boehringer Ingelheim, Sopharma, others | AstraZeneca, Amgen |
Efficacy
Clenbuterol Efficacy in Asthma Management
Clenbuterol is a bronchodilator that is not typically approved for the treatment of asthma in many countries, including the United States. However, it has been used in some places for its off-label use in the management of this respiratory condition. Clenbuterol works by relaxing the muscles in the airways, which can help to alleviate the symptoms of asthma such as shortness of breath, wheezing, and coughing. Its efficacy in asthma is related to its ability to increase the airflow to the lungs, but it is not considered a first-line treatment due to the availability of more effective and safer asthma medications.
Despite its potential use, Clenbuterol's safety profile and the risk of side effects such as tremors, headache, and palpitations have limited its use in asthma therapy. Additionally, there are concerns about its long-term effects and potential for misuse, as it is also known to have anabolic properties, which can lead to its abuse by athletes for performance enhancement. Therefore, its efficacy in asthma must be weighed against its safety and the legal implications of its use.
Tezepelumab-Ekko (Tezspire) Efficacy in Asthma Treatment
Tezepelumab-ekko, marketed under the brand name Tezspire, represents a novel approach in the treatment of asthma, particularly for patients with severe asthma who do not respond well to standard treatments. It is a monoclonal antibody that targets thymic stromal lymphopoietin (TSLP), an upstream regulator of multiple inflammatory pathways associated with asthma. By inhibiting TSLP, Tezspire can reduce the inflammation that contributes to asthma symptoms and exacerbations.
Clinical trials have demonstrated the efficacy of Tezspire in reducing the annual asthma exacerbation rate in patients with severe, uncontrolled asthma. It has been shown to be effective in a broad population of severe asthma patients, regardless of their baseline eosinophil counts or other biomarkers. This broad efficacy makes Tezspire a promising treatment option for a wide range of patients suffering from severe asthma, offering potential improvements in lung function, asthma control, and quality of life.
Regulatory Agency Approvals
Clenbuterol
-
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Tezspire
-
Food and Drug Administration (FDA), USA
Access Clenbuterol or Tezspire today
If Clenbuterol or Tezspire are not approved or available in your country (e.g. due to supply issues), you can access them via Everyone.org.
How it works
Make an enquiry
Choose the medicine you want to buy, answer a couple of questions, and upload your prescription to speed things up. We’ll get back to you within 24 hours.
Make an enquiry
Choose the medicine you want to buy, answer a couple of questions, and upload your prescription to speed things up. We’ll get back to you within 24 hours.
Breeze through the paperwork
We'll guide you through the required documents for importing unapproved medicine, ensuring you have all the necessary information.
Get a personalized quote
We’ll prepare a quote for you, including medicine costs and any shipping, administrative, or import fees that may apply.
Receive your medicine
Accept the quote and we’ll handle the rest - sourcing and safely delivering your medicine.
Some text on this page has been automatically generated. Speak to your physician before you start a new treatment or medication.
Let's talk
If you have any questions, call us or send us a message through WhatsApp or email:
Contact us